Cita APA

Castillo, L., Young, A. I. J., Mawson, A., Schafranek, P., Steinmann, A. M., Nessem, D., . . . Oakes, S. R. (2019). MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma. Oncogene.

Chicago Style Citation

Castillo, Lesley, et al. "MCL-1 Antagonism Enhances the Anti-invasive Effects of Dasatinib in Pancreatic Adenocarcinoma." Oncogene 2019.

Cita MLA

Castillo, Lesley, et al. "MCL-1 Antagonism Enhances the Anti-invasive Effects of Dasatinib in Pancreatic Adenocarcinoma." Oncogene 2019.